- Home
- SEGG vs GOVX Comparison
SEGG vs GOVX Comparison
Compare SEGG & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEGG
- GOVX
- Stock Information
- Founded
- SEGG N/A
- GOVX 2001
- Country
- SEGG United States
- GOVX United States
- Employees
- SEGG 12
- GOVX N/A
- Industry
- SEGG Computer Software: Prepackaged Software
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- SEGG Technology
- GOVX Health Care
- Exchange
- SEGG Nasdaq
- GOVX Nasdaq
- Market Cap
- SEGG 19.7M
- GOVX 16.8M
- IPO Year
- SEGG 2023
- GOVX N/A
- Fundamental
- Price
- SEGG $4.04
- GOVX $0.55
- Analyst Decision
- SEGG
- GOVX Strong Buy
- Analyst Count
- SEGG 0
- GOVX 3
- Target Price
- SEGG N/A
- GOVX $10.67
- AVG Volume (30 Days)
- SEGG N/A
- GOVX 1.0M
- Earning Date
- SEGG N/A
- GOVX 11-11-2025
- Dividend Yield
- SEGG N/A
- GOVX N/A
- EPS Growth
- SEGG N/A
- GOVX N/A
- EPS
- SEGG N/A
- GOVX N/A
- Revenue
- SEGG N/A
- GOVX $6,143,044.00
- Revenue This Year
- SEGG N/A
- GOVX N/A
- Revenue Next Year
- SEGG N/A
- GOVX N/A
- P/E Ratio
- SEGG N/A
- GOVX N/A
- Revenue Growth
- SEGG N/A
- GOVX 1943.07
- 52 Week Low
- SEGG N/A
- GOVX $0.43
- 52 Week High
- SEGG N/A
- GOVX $3.88
- Technical
- Relative Strength Index (RSI)
- SEGG 41.60
- GOVX 36.02
- Support Level
- SEGG $3.80
- GOVX $0.46
- Resistance Level
- SEGG $4.61
- GOVX $0.59
- Average True Range (ATR)
- SEGG 0.38
- GOVX 0.04
- MACD
- SEGG -0.23
- GOVX -0.01
- Stochastic Oscillator
- SEGG 12.77
- GOVX 33.63
About SEGG Lottery.com Inc. Common Stock
Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.